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Abstract Urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) has 
been reported to serve as a sensitive biomarker of oxidative DNA 
damage and also of oxidative stress. We have investigated 
oxidative DNA damage in patients with non-insulin-dependent 
diabetes mellitus (NIDDM) by urinary 8-OHdG assessments. 
We determined the total urinary excretion of 8-OHdG from 24 h 
urine samples of 81 N I D D M patients 9 years after the initial 
diagnosis and of 100 non-diabetic control subjects matched for 
age and gender. The total 24 h urinary excretion of 8-OHdG was 
markedly higher in N I D D M patients than in control subjects 
(68.2 ± 39.4 /ig vs. 49.6 ± 37.7 fig, P = 0.001). High glycosylated 
hemoglobin was associated with a high level of urinary 8-OHdG. 
The increased excretion of urinary 8-OHdG is seen as indicating 
an increased systemic level of oxidative DNA damage in 
N I D D M patients. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Reactive oxygen species (ROS) and oxidative stress may be 
crucial for the development of the vascular complications of 
diabetes [1-3]. Hyperglycemia leads to autoxidation of glucose 
[2] and causes consequent glycooxidation of proteins as well 
as low-density lipoprotein (LDL). This is, in turn, associated 
with vascular changes and atherosclerosis [2,4]. 
8-Hydroxy-2'-deoxyguanosine (8-OHdG) is a product of 
oxidative D N A damage following specific enzymatic cleavage 
after 8-hydroxylation of the guanine base. 8-OHdG increases 
in plasma with aging [5], during the development of tumors 
caused by ROS [6], during radiotherapy [7] and in smokers [8]. 
Urinary 8-OHdG is a new putative biomarker of the total 
systemic oxidative stress in vivo [9,10]. 
Mononuclear cells of diabetic patients have recently been 
reported to contain a high level of 8-OHdG [11], but there are 
overall very few data on oxidative D N A damage in patients 
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with diabetes. Thus, we have measured urinary 8-OHdG in a 
cohort of non-insulin-dependent diabetes mellitus ( N I D D M ) 
patients 9 years after diagnosis. 
2. Materials and methods 
The study group consisted of 81 NIDDM outpatients at the munic-
ipal health care center of the City of Tampere. The patients fulfilled 
the WHO diagnostic criteria for NIDDM. One hundred non-diabetic 
attendants of the same health care center, matched for age and gen-
der, were used as control subjects. All subjects gave written informed 
consent. The study was approved by the ethics committees of the 
Tampere University Hospital and the health care center of the City 
of Tampere. The recruitment of patients and control subjects and the 
diagnostic criteria have been previously discussed in detail [12]. Sub-
jects with disseminated cancer and a reduced life expectancy were 
excluded from both groups. Some biochemical and demographic char-
acteristics of the study groups are presented in Table 1. At the time of 
study 11 patients were treated with diet alone, 47 patients with an oral 
antidiabetic drug, and 23 patients were on insulin. 
2.1. Methods 
All blood samples were collected after an overnight fast. Serum 
cholesterol and triglycérides were determined by the dry slide tech-
nique (Ektachem 700 analyzer, Johnson and Johnson Clinical Diag-
nostics, Rochester, NY, USA). High-density lipoprotein (HDL) chol-
esterol was measured with the same technique after precipitation of 
LDL. Blood glucose, glycosylated hemoglobin (HbAic) and urinary 
albumin were determined by routine laboratory methods. The glomer-
ular filtration rate (GFR) was determined by the plasma clearance of 
[51Cr]EDTA assessed by the single injection method [13]. Urinary 
creatinine was measured with Creatinine-Test (Wako, Osaka, Japan). 
The body mass index (BMI) was calculated as body weight (kg)/ 
height2 (m). A doctor asked about cigarette smoking (yes/no at 
present time). 
A 2 ml sample of a well-mixed 24 h urine collection was stored 
frozen at —70°C until analyzed. Urine samples were centrifuged at 
lOOOOXg for 10 min, and after proper dilution the supernatant was 
used for the determination of 8-OHdG by a competitive ELISA (8-
OHdG Check, Japan Institute for the Control of Aging, Fukuroi, 
Shizuoka). The determination range was 0.64-2000 ng/ml. The speci-
ficity of the monoclonal antibody N45.1 used in the competitive ELI-
SA kit has been established [14]. Urinary 8-OHdG is expressed as the 
total amount excreted in 24 h. The urinary 8-OHdG/creatinine ratio 
was alternatively used in analysis with consistent results. 
Analysis of covariance (ANCOVA) was used to compare 8-OHdG 
excretion between groups. The dependent factors in ANCOVA were 
NIDDM, smoking and gender, and BMI was used as a covariate. 
Pearson's correlation matrix was used for correlation analysis. Com-
putations were carried out using Statistica for Windows ver. 5.0 (Stat-
soft Inc., Tulsa, OK, USA). Data in the text are given as mean± 
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Table 1 
Biochemical, clinical and demographic characteristics of the study groups 
NIDDM patients Control subjects 
54/46 
65.0 ±6.9 
18 (18.0%) 
27.7 ±4.5 
4.9 ±1.0 
11.8±6.9 
5.7 ±0.7 
1.5±0.8 
5.7 ±1.2 
1.2 ±0.4 
153 ±20/87 ±8 
21.3±53.7 
90.5 ±19.7 
Gender (male/female, ri) 
Age (years) 
Smokers (n) 
Duration of disease (years) 
BMI (kg/m2) 
Fasting blood glucose (mM) 
Fasting serum insulin (IU) 
HbAl C (%) 
Triglycérides (mM) 
Total cholesterol (mM) 
HDL cholesterol (mM) 
Blood pressure (mm Hg, syst/diast) 
24 h urinary albumin (mg) 
GFR (ml/min/1.73 m2) 
49/32 
64.6 ±7.5 
8 (9.9%) 
9.4 ±0.8 
30.0 ±5.3* 
9.3 ±3.0* 
31.7 ±76.2* 
8.3 ±1.6* 
2.0±1.3* 
5.3 ±1.0* 
1.1 ±0.4 
162±21*/88±9 
97.0±215* 
97.7 ±23.4 
Results are means ± S.D. *P<0.05 between groups. 
standard deviation (S.D.). A P value less than 0.05 was considered 
significant. 
3. Results 
The total 24 h urinary 8-OHdG excretion was 68.2 ± 39.4 
|xg in NIDDM patients and 49.6 ± 37.7 |xg in control subjects 
(P = 0.001) (35.9 ±16.4 vs. 24.3 ±15.2 ng/mg creatinine, re-
spectively, P< 0.0001). In three-way ANCO VA the impact 
of smoking and gender weakened this difference between dia-
betic patients and control subjects (Fig. 1). A detailed analysis 
showed that male subjects had a markedly higher urinary 
excretion of 8-OHdG than the corresponding female subjects 
(80.8 ±44.6 vs. 48.9 ± 16.8 ug, P = 0.0002, in diabetic patients, 
and 62.4 ±42.0 vs. 34.6 ±24.9 ug, i> = 0.0001, in control sub-
jects). Smoking increased the urinary 8-OHdG excretion only 
in the control subjects, and thus the difference between dia-
betic patients and control subjects was diminished in smokers 
(Fig. 1). 
The patients were divided into three groups according to 
their level of HbAiC. The group in poorest glycémie control 
included patients with H b A ^ in the upper quartile, i.e. pa-
tients with HbAiC higher than 9.6%, the second group com-
prised patients with HbAtC between 6.8% and 9.6%, while the 
patient group in best glycémie control had HbAiC in the lower 
quartile, i.e. less than 6.8%. In one-way ANCOVA there were 
significant differences in the level of urinary 8-OHdG between 
these groups (P = 0.04) (Fig. 2). The group of patients in 
poorest glycémie control had total urinary excretion of 8-
OHdG 56%o higher than the group in best glycémie control 
(P = 0.009) and 77% higher than the control subjects 
(P = 0.00004). On the other hand, the difference in urinary 
8-OHdG between patients in best glycémie control and con-
trol subjects was not statistically significant. The same effect 
of blood glucose control on urinary 8-OHdG was also ob-
served separately in male, female, and non-smoking patients. 
The total 24 h urinary excretion of 8-OHdG had a weak 
positive correlation with GFR both in NIDDM patients 
(r = 0.28, P = 0.03) and in control subjects (r = 0.29, 
P = 0.02), but no correlation with 24 h urinary albumin was 
observed. Urinary 8-OHdG also had no significant correla-
tions with BMI, blood cell count, blood pressure, serum fast-
ing insulin, or lipid related variables. 
4. Discussion 
Fig. 1. 24 h urinary 8-OHdG excretion in NIDDM patients and 
control subjects by gender and smoking. *P<0.01 between diabetic 
patients and control subjects. 
Urinary 8-OHdG is a new index of systemic oxidative DNA 
damage that has been repaired [15]. 8-OHdG passes freely 
into the urine by glomerular filtration and serves as an index 
of whole body oxidative stress [9]. Immunological assessment 
of 8-OHdG yields comparable results to the HPLC-based 
method [16], which is more commonly used, but is more con-
venient for non-invasive studying of large numbers of urine 
samples. However, the metabolism of 8-OHdG has not been 
thoroughly elucidated in humans and some of the 8-OHdG 
may arise from deoxyGTP, a DNA precursor base [17]. It is 
not established whether urinary 8-OHdG originates from liv-
ing or dead cells [18], although secretion from living cells is 
supported. All mammalian cells contain enzymatic activity 
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Fig. 2. The 24 h urinary excretion of 8-OHdG in NIDDM patients 
according to the level of HbAiC (mean+S.D.). The horizontal line 
represents the mean 24 h urinary excretion of 8-OHdG of control 
subjects. 
specifically cleaving 8-OHGua-containing D N A [19]. The diet 
apparently does not affect the urinary excretion of 8-OHdG 
[20]. 
The present study indicates an increased oxidative D N A 
damage in N I D D M patients 9 years after diagnosis. Addition-
ally, the highest excretion level of urinary 8-OHdG was seen 
in male smokers. The difference in urinary 8-OHdG between 
patients and control subjects was also diminished in smoking 
subjects. However, the small number of smokers (n = 8) 
among N I D D M patients prevented reliable analysis of the 
possible additive effect of smoking on urinary 8-OHdG. 
Poor glycémie control was associated with a high urinary ex-
cretion of 8-OHdG. This finding is in good agreement with 
the idea of oxidative stress in N I D D M originating from con-
stant hyperglycemia. An association between poor glycémie 
control in N I D D M and oxidative stress has been previously 
demonstrated and discussed [1,2,4,21,22]. 
Oxidative D N A damage and 8-OHdG have been exten-
sively studied in relation to the development of cancer [6,8]. 
In diabetes mellitus, however, there is no increased risk for 
cancer, despite the increased systemic D N A damage implied 
by the high excretion of 8-OHdG in this study. Oxidative 
D N A damage has, however, been shown to be related to 
the peroxidation of membrane fatty acids and low antioxidant 
status [23], both present in diabetes. 
In conclusion, we found high urinary excretion of 8-OHdG 
in N I D D M patients, especially in patients with poor blood 
glucose control. The full meaning of this increased systemic 
oxidative D N A damage in diabetes is unknown and requires 
further elucidation. 
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